Multimessenger observations of a flaring blazar coincident with high-energy neutrino IceCube-170922A | Science
![Multimessenger observations of a flaring blazar coincident with high-energy neutrino IceCube-170922A | Science Multimessenger observations of a flaring blazar coincident with high-energy neutrino IceCube-170922A | Science](https://www.science.org/cms/10.1126/science.aat1378/asset/7f24ac36-c05c-4da1-8da1-a0a13fcb309a/assets/graphic/361_aat1378_f2.jpeg)
Multimessenger observations of a flaring blazar coincident with high-energy neutrino IceCube-170922A | Science
![Multimessenger observations of a flaring blazar coincident with high-energy neutrino IceCube-170922A | Science Multimessenger observations of a flaring blazar coincident with high-energy neutrino IceCube-170922A | Science](https://www.science.org/cms/asset/ff3e9ca3-efce-4116-b242-b15d39b01794/science.2018.361.issue-6398.largecover.jpg)
Multimessenger observations of a flaring blazar coincident with high-energy neutrino IceCube-170922A | Science
![Multimessenger observations of a flaring blazar coincident with high-energy neutrino IceCube-170922A | Science Multimessenger observations of a flaring blazar coincident with high-energy neutrino IceCube-170922A | Science](https://www.science.org/cms/10.1126/science.aat1378/asset/7313b9d8-78de-478f-87ff-d9a9540516dc/assets/graphic/361_aat1378_fa.jpeg)
Multimessenger observations of a flaring blazar coincident with high-energy neutrino IceCube-170922A | Science
![Frontiers | A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner Frontiers | A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner](https://www.frontiersin.org/files/Articles/580974/fimmu-11-580974-HTML-r1/image_m/fimmu-11-580974-g002.jpg)
Frontiers | A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner
![Frontiers | A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner Frontiers | A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner](https://www.frontiersin.org/files/MyHome%20Article%20Library/580974/580974_Thumb_400.jpg)
Frontiers | A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner
![Frontiers | A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner Frontiers | A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner](https://www.frontiersin.org/files/Articles/580974/fimmu-11-580974-HTML-r1/image_m/fimmu-11-580974-g001.jpg)
Frontiers | A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner
![Frontiers | A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner Frontiers | A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner](https://www.frontiersin.org/files/Articles/580974/fimmu-11-580974-HTML-r1/image_m/fimmu-11-580974-g003.jpg)